µfluidic applications: an upcoming Eldorado for µelectronic ?
By Dr Christine Peponnet,
Head of Bio System on Chip Group,
The More than Moore common roadmaps usually encompass a large domain of applications incorporating sensors and actuators of all kind in photonics, imagers, RF, and MEMS. However in order to be able to address the next big market which is healthcare and environmental monitoring, sensing molecules is the forthcoming challenge! Microfluidics which manipulates small volumes of gaz and liquids is the key enabling technology for molecules sampling and preparation needed before the sensing step.
However, today this strategic need for delocalised devices in life sciences: pharmaceutical, personalized medicine, environmental, analytical, agro-food, etc are only partially addressed because of limited availability of mature and modular microfluidic products and solutions.
Indeed, microfluidic needs to work in two directions which are standardization of interconnects and the establishment of a structured industrial and efficient supply chain capable of working with heterogeneous materials (Silicon, Glass, and Polymers). Some initiative are currently on going such as the MF-3 consortium on standardization and some European initiatives concerning the microfluidic supply chain (design kits, standard and validated process, …) in order to pick up the challenge of moving from today’s “spider assembly” to “Fluidic circuit boards” !
Having a PhD in human genetics, she worked at Genset for 12 years. First on the development of HLA DRB DNA genotyping Kits, then as the genotyping R&D lab manager where she contributed along with her coworkers to the development of new high throughput genotyping methods based on microfluidic.
From 2001 to 2003, she worked in the US at Caliper technology, leader in commercializing lab on a chip and associated instruments for high throughput screening systems, where she was in charge of developing an SNP genotyping assay on their continuous flow microfluidic platform.
Since 2006, she is heading the Biosystems on chip group at CEA/Leti in the Dept of Systems for Biology and Health Care, which is involved in system developments requiring microfluidic, microtechnology, chemistry and biology.